BPC/TB500 Blend

$69.99

Manufactured in the USA

View batch COA

Protective packaging

Secure checkout

Description

A two-peptide research blend of BPC-157 and TB-500 in equal amounts. Supplied as a lyophilized powder in sealed vials. Each batch has its own certificate of analysis (COA), which opens when you scan the QR code on the label. For laboratory research use only. Not for human or veterinary use.

Research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease.

Research profile

BPC-157 + TB-500 blend research profile

This is a multi-component research material containing BPC-157 (a synthetic 15-residue peptide, GEPPPGKPADDAGLV) and TB-500 (the N-acetylated thymosin beta-4 fragment Ac-LKKTETQ) in one vial. Each component's identity is shown on the certificate of analysis. Published research covers each peptide separately; there are no published studies on the blend itself.

Specifications

Composition: BPC-157 + TB-500 fragment; amount of each component is stated on the label
BPC-157 sequence: GEPPPGKPADDAGLV; C62H98N16O22, ≈ 1419.6 g/mol (CAS 137525-51-0)
TB-500 sequence: Ac-LKKTETQ (thymosin beta-4 residues 17–23); C38H68N10O14, ≈ 889.0 g/mol (CAS 885340-08-9)
Size: 10MG/10MG / 20MG/20MG per vial
Form: Lyophilized powder, sealed vial
Storage: Keep sealed, protected from light and moisture; follow the label
Testing: HPLC purity and mass spectrometry identity, per lot. Scan the QR code on the vial for the certificate of analysis.

Published research

BPC-157: rat Achilles tendon transection with in vitro tendocyte culture (Staresinic et al., J Orthop Res, 2003); tendon fibroblasts in culture (Chang et al., J Appl Physiol, 2011).
BPC-157: angiogenesis in rat hind-limb ischemia and endothelial cell culture (Hsieh et al., J Mol Med, 2017).
TB-500 / thymosin beta-4: main actin-sequestering protein in cells (Safer et al., J Biol Chem, 1991); topical TB-500 in mouse skin wound models (Huang et al., Proteomics, 2006).
Thymosin beta-4: mouse coronary ligation and cultured cardiomyocytes (Bock-Marquette et al., Nature, 2004).

Read the guide BPC-157 vs TB-500: two research peptides compared

Frequently asked questions

Which form of TB-500 is in the blend?

The 7-residue fragment Ac-LKKTETQ (≈ 889 g/mol), not full-length thymosin beta-4. The mass spectrometry result on the COA confirms each component.

Is there published research on this blend?

No. Published studies examine each component on its own; we are not aware of literature on this combination. The research notes above summarize each component separately.

How do I verify my lot?

Scan the QR code on the vial. It opens the certificate of analysis for that lot, with HPLC purity and the mass spectrometry identity result.

For laboratory research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease. Literature references are provided for scientific context and do not describe this product's suitability for any use.